Profil de l'entreprise · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · Shanghai
Pays / Région
China
Date d'introduction en bourse
23 avril 2004
Effectif
2 544
Buffett Score
72/100
Solide
Capitalisation9,71 Md CNY
Chiffre d'affaires (TTM)3,93 Md CNY
EBITDA710,27 M CNY
Marge nette15,29 %
ROE14,16 %
PER (TTM)16,2
PER prévisionnel23,42
BPA1,39 CNY
Rendement du dividende3,15 %
Fourchette sur 52 semaines21,22 CNY – 30,18 CNY

Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Historique

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Position dans le secteur

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Pas encore d'analyse sur cette valeur dans votre langue.